Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Congenital Abnormalities × liposomal doxorubicin × Clear all

Sponsor

Conditions

Ovarian Neoplasms 27 Breast Neoplasms 19 Fallopian Tube Neoplasms 18 Multiple Myeloma 14 Carcinoma, Ovarian Epithelial 12 Lymphoma 7 Triple Negative Breast Neoplasms 4 Neoplasms, Plasma Cell 3 Prostatic Neoplasms 2 Neoplasms 2 Lymphoma, T-Cell, Peripheral 2 Lymphoma, Large B-Cell, Diffuse 2 Hodgkin Disease 2 Burkitt Lymphoma 2 Subcutaneous panniculitis-like T-cell lymphoma 1 Solid Tumors 1 Sarcoma, Synovial 1 Sarcoma, Kaposi 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Recurrence 1 Peritoneal Neoplasms 1 Patient Participation 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Neurofibrosarcoma 1 Neuroendocrine Tumors 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1

Interventions

fludarabine phosphate 32 Cytarabine 29 Cyclophosphamide 24 Whole-Body Irradiation 23 Peripheral Blood Stem Cell Transplantation 23 Mycophenolic Acid 22 Busulfan 21 Tacrolimus 19 Cyclosporine 15 Filgrastim 14 Etoposide 14 Antilymphocyte Serum 14 Methotrexate 13 Melphalan 11 Idarubicin 9 Granulocyte Colony-Stimulating Factor 9 Clofarabine 8 Mitoxantrone 7 Flow Cytometry 7 Sirolimus 6 Radiotherapy 6 Cord Blood Stem Cell Transplantation 6 aldesleukin 5 Vorinostat 5 Daunorubicin 5 thymoglobulin 4 fludarabine 4 alvocidib 4 Thiotepa 4 Polymerase Chain Reaction 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡